The Counter Does Not Care Who Drew the Blood
Five new UnitedHealthcare reimbursement policies take effect September 1 across commercial, the exchanges, and Medicare Advantage. They name 37 lab codes, stop paying 17 of them outright, and run every frequency counter at the member level, so the reference lab's claim spends the same allowance your office draw needs. Seven states are excepted, and they are the same seven that ran 62 to 121 days behind the first tranche.
The effective date column in UnitedHealthcare's June reimbursement bulletin does not say September 1. It says "9/1/2026, for all states except AR, CO, KY, NC, NE, OH, and RI," and then promises a later notification for those seven.
Five new policies, five identical date cells, the same seven states carved out of each one.
All five are laboratory policies: Allergen Testing (2026R8021A), Hepatic Fibrosis Testing for Chronic Liver Disease (2026R8022A), In Vitro Chemotherapy Assays (2026R8019A), Testosterone (2026R8020A), and Vitamin B12 Testing (2026R8014A). Published June 1, posted for review June 8, live September 1.
Between them they name 37 distinct codes, put hard frequency counters on eleven, and stop paying seventeen outright.
UnitedHealthcare Gave the Program a Name
Each of the five is titled "Routine Test Management" plus the test. The August Medicare Advantage bulletin has already shortened it to RTM in its own code-update table, which means the acronym is now inside the payer's published documents and will start showing up in provider-rep email.
These are reimbursement policies, and the distinction is the whole point. The bulletin that launched the program describes the enforcement as "automated post-service, pre-payment policy enforcement," applied to claims for lab services performed in office, hospital outpatient, and independent laboratory locations.
The claim meets the counter before anyone pays it.
Three settings sit outside: emergency rooms, hospital observation units, and hospital inpatient.
RTM is not new. 18 policies shipped under it on December 1, 2025, covering flow cytometry, iron homeostasis, Lyme disease, fecal calprotectin, autoimmune rheumatic disease, chronic heart failure, intracellular micronutrient analysis and a dozen more.
A separate Vitamin D policy followed on April 1 at four tests per year, denied outright without an ICD-10 diagnosis from the list the policy publishes.
Add September's five to December's eighteen and the Routine Test Management shelf carries 23 policies across two effective dates nine months apart.
The rest of this brief is for subscribers.
The impact tables, the code-level detail, and the rest of the analysis sit past this line.
$50 a month, or $500 a year.
Already a subscriber? Sign in